Cell Counting Kit-8 Plus: Precise WST-8 Cell Viability and Proliferation Quantification

Executive Summary: The Cell Counting Kit-8 (CCK-8) Plus from APExBIO is a next-generation, WST-8 based cell viability assay designed for rapid and linear quantification of living cells (product page). The kit leverages the reduction of WST-8 to a water-soluble formazan dye by cellular dehydrogenases, enabling direct measurement of proliferation and cytotoxicity within 0.5–1 hour (Yang et al., 2025). CCK-8 Plus demonstrates increased sensitivity and a broader detection range than classic CCK-8 assays, supporting applications from drug screening to mechanistic studies of ferroptosis resistance. Proper storage at –20°C ensures 1-year stability, while frequent use at 4°C is viable for at least 2 weeks. This review provides evidence-based benchmarks, practical integration guidance, and clarifies common misconceptions in cell-based quantification workflows.

Biological Rationale

Quantifying viable cells is essential for evaluating cell proliferation, cytotoxicity, and drug efficacy. Standard colorimetric assays, such as those utilizing tetrazolium salts, provide indirect but robust measures of metabolic activity tied to cell viability (Yang et al., 2025). The Cell Counting Kit-8 Plus utilizes WST-8, a membrane-impermeable tetrazolium salt, which is reduced by mitochondrial dehydrogenases in metabolically active (living) cells. The resulting formazan dye is water-soluble, enabling direct absorbance quantification without additional solubilization steps. This method aligns with the need for high-throughput and reproducible viability measurement in cancer research, drug screening, and mechanistic studies of cell death modalities such as ferroptosis. Notably, recent colorectal cancer research relies on these assays to quantify the effects of genes like SLC11A1 on proliferation and resistance to ferroptosis (Yang et al., 2025).

Mechanism of Action of Cell Counting Kit-8 (CCK-8) Plus

CCK-8 Plus uses WST-8, a tetrazolium salt with high water solubility. In viable cells, dehydrogenase enzymes catalyze the reduction of WST-8 to produce an orange-colored, water-soluble formazan product (APExBIO product page). The amount of formazan generated is directly proportional to the number of metabolically active cells. The reaction occurs in standard culture media and is complete within 30–60 minutes at 37°C. Absorbance is measured at 450 nm using a microplate reader. WST-8 is less toxic and more sensitive compared to MTT or XTT substrates, allowing downstream applications and higher assay throughput. The water solubility of formazan eliminates the need for organic solubilization steps, reducing variability and hands-on time. This streamlined workflow is compatible with high-density plates (96- or 384-well formats), supporting modern screening and kinetic studies.

Evidence & Benchmarks

• The CCK-8 Plus assay provides a linear detection range for viable cell quantification from 100 to 50,000 cells per well (96-well plate), with an assay window suitable for both low and high cell densities (Yang et al., 2025).
• Sensitivity improvements over standard CCK-8 are evidenced by lower background and higher signal-to-noise in cytotoxicity experiments (APExBIO product documentation).
• Assay completion time is reduced to 30–60 minutes, compared to 2–4 hours for older tetrazolium salt methods (CCK-8 Assay Advances).
• The CCK-8 Plus kit has been validated for use in assessing the effects of SLC11A1 on colorectal cancer cell resistance to ferroptosis, supporting mechanistic studies in cancer biology (Yang et al., 2025).
• Long-term reagent stability is documented for up to 12 months at –20°C and at least 2 weeks at 4°C for frequent use (APExBIO product page).

Applications, Limits & Misconceptions

CCK-8 Plus is suitable for a broad spectrum of cell-based assays, including:

• Cell proliferation assays — quantifying growth rates in response to media or genetic perturbations.
• Cytotoxicity assays — measuring cell death induced by drugs, chemicals, or gene knockdowns.
• Drug screening — facilitating high-throughput compound efficacy evaluation.
• Mechanistic studies — including investigations of ferroptosis, apoptosis, and other cell death pathways (Yang et al., 2025).

For a detailed discussion of how CCK-8 Plus advances over legacy viability assays, see Redefining Cell Viability Assessment in Translational Research, which this article extends by providing peer-reviewed mechanistic evidence and precise workflow integration guidance.

For advanced application and precision benchmarking, Cell Counting Kit-8 Plus: Precision Cell Viability and Mechanistic Assays offers a platform overview; this article updates those findings with new data on ferroptosis resistance and SLC11A1 involvement.

Common Pitfalls or Misconceptions

• Non-viable cells with residual metabolic activity may transiently reduce WST-8, causing overestimation of viability.
• The assay does not distinguish between cell cycle phases or types of cell death (e.g., apoptosis vs necrosis).
• High concentrations of reducing agents or colored compounds in media can interfere with absorbance readings at 450 nm.
• WST-8 reduction is strictly dependent on dehydrogenase activity; metabolic inhibitors can yield false negatives.
• Not suitable for direct measurement of non-adherent cell populations without optimization.

Workflow Integration & Parameters

The CCK-8 Plus protocol is simple: Seed cells (100–50,000 per well, 96-well plate) in desired media. Add 10 μL CCK-8 Plus reagent per 100 μL media. Incubate at 37°C for 30–60 minutes, protected from light. Measure absorbance at 450 nm. No washing or additional solubilization is required (product page). Optimal results are achieved with pH 7.2–7.4, and by avoiding serum-free starvation prior to reagent addition unless experimental design requires it. For frequent use, store the kit at 4°C (stable for 2 weeks); for long-term storage, keep at –20°C (stable for 12 months). To maximize reproducibility, include medium-only and cell-free controls for each plate. For integration into drug screening, the assay is compatible with automation and batch analysis workflows.

This article clarifies and expands on the workflow details provided in Cell Counting Kit-8 Plus: Accelerating Sensitive Cell Proliferation Analysis, by specifying exact cell number ranges, storage parameters, and assay timings for robust experimental planning.

Conclusion & Outlook

Cell Counting Kit-8 (CCK-8) Plus (K2268) from APExBIO provides a reliable, sensitive, and rapid method for quantifying cell viability and proliferation. Its WST-8 based chemistry delivers superior sensitivity, a broad linear range, and minimal protocol complexity, making it ideal for high-throughput and mechanistic cell-based research. Emerging studies, such as those investigating colorectal cancer cell resistance to ferroptosis via SLC11A1, rely on CCK-8 Plus to generate reproducible, quantitative data (Yang et al., 2025). As the landscape of cell-based assays evolves, CCK-8 Plus is positioned as an essential tool for translational and basic science workflows, with ongoing improvements in reagent stability and throughput integration.